News

Pharmabiz46m
EMA’s safety committee concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus & Wegovy
EMA’s safety committee concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus & Wegovy: Amsterdam, The Netherlands Monday, June 9, 2 ...
Pharmabiz1h
Sobi & Apellis’ Aspaveli/Empaveli demonstrates sustained one-year efficacy in phase 3 study for rare kidney diseases
Sobi & Apellis’ Aspaveli/Empaveli demonstrates sustained one-year efficacy in phase 3 study for rare kidney diseases: Stockholm Monday, June 9, 2025, 10:00 Hrs [IST] Sobi, a glo ...
Pharmabiz2h
UK MHRA launches new digital hub in Leeds to drive innovation and regional growth
UK MHRA launches new digital hub in Leeds to drive innovation and regional growth: United Kingdom Monday, June 9, 2025, 09:00 Hrs [IST] A new digital hub in Leeds is being launche ...
Pharmabiz3h
Indian pharma grapples headwinds of US pricing reform & Europe’s HTA-driven cost-effectiveness: Akash Kedia
Indian pharma grapples headwinds of US pricing reform & Europe’s HTA-driven cost-effectiveness: Akash Kedia: Nandita Vijayasimha, Bengaluru Monday, June 9, 2025, 08:00 Hrs [IST] ...
Pharmabiz3h
TNPDA to revitalize association by affiliating with AICDF
The office-bearers of the Tamil Nadu Pharmaceutical Distributors Association (TNPDA) are taking steps to revitalize the association by affiliating with the All India Chemists and Distributors ...
Pharmabiz3h
CDSCO’s guidance document specifies disposal methods of expired & unused drugs
CDSCO’s guidance document specifies disposal methods of expired & unused drugs: Gireesh Babu, New Delhi Monday, June 9, 2025, ...
Pharmabiz3h
Govt intensifying focus on excipient manufacturing under PLI scheme to break import dependency
Govt intensifying focus on excipient manufacturing under PLI scheme to break import dependency: Shardul Nautiyal, Mumbai Monday, June 9, 2025, 08:00 Hrs [IST] Aiming to drasticall ...
Pharmabiz3h
Import of bulk drugs declines 2.32 per cent in April
Imports of bulk drugs and intermediates to India have seen a decline of 2.32 per cent during the first month of the current fiscal year, at $368.65 million as against the $377.42 million same period ...
Pharmabiz1d
Autonomix Medical receives approval from Republic of Uzbekistan to expand proof-of-concept human clinical study
Autonomix Medical receives approval from Republic of Uzbekistan to expand proof-of-concept human clinical study: The Woodlands, Texas Saturday, June 7, 2025, 18:00 Hrs [IST] Auton ...
Pharmabiz1d
CancerVax creates a ligand conjugated nanoparticle to target specific biomarkers on surface of cancer cells
CancerVax creates a ligand conjugated nanoparticle to target specific biomarkers on surface of cancer cells: Lehi, Utah Saturday, June 7, 2025, 17:00 Hrs [IST] CancerVax, Inc, the ...
Pharmabiz1d
Ocugen signs binding term sheet for license of OCU400 modifier gene therapy for retinitis pigmentosa in Korea
Ocugen signs binding term sheet for license of OCU400 modifier gene therapy for retinitis pigmentosa in Korea: Malvern, Pennsylvania Saturday, June 7, 2025, 16:00 Hrs [IST] Ocugen ...
Pharmabiz1d
Oncovita secures US FDA orphan drug designation for its lead oncolytic virus candidate, MVdeltaC to treat pleural mesothelioma
Oncovita secures US FDA orphan drug designation for its lead oncolytic virus candidate, MVdeltaC to treat pleural mesothelioma: Paris Saturday, June 7, 2025, 15:00 Hrs [IST] Oncov ...